Targeted therapies: A new generation of cancer treatments

DE Gerber , American Family Physician , February 2008; (2008 Feb 1; 77(3)):294,296

The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas

DE Gerber, SA Grossman, M Zeltzman, MA Parisi, L Kleinberg , Neuro-oncology , 2007; (9(1)):47-52

Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphoma

DE Gerber, SA Grossman, T Batchelor, X Ye , Cancer Chemotherapy and Pharmacology , 2007; (59(6)):817-23

The management of venous thromboehmbolism in patients with primary and metastatic brain tumors

DE Gerber, SA Grossman, MB Streiff , Journal of Clinical Oncology , 2006; (24(8)):1310-8

The Incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1,514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention.

Gerber DE, Segal JB, Levy MY, Kane J, Jones RJ, Streiff MB. , Blood , ; (2008 May 14)